Eloralintide
Lilly Prepares Amylin-Based Obesity Drug Eloralintide for Phase III After Strong Weight Loss Results
Eli Lilly; eloralintide; amylin agonist; obesity drug; Phase III trial; weight loss; clinical development
Lilly Posts Encouraging Early-Stage Weight Loss Data on Amylin Candidate
Eli Lilly; eloralintide; amylin candidate; weight loss; early-stage trial; obesity drug; clinical data; side effects